Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures

Richard C. Becker; James Scheiman; Harold L. Dauerman; Frederick Spencer; Sunil Rao; Marc Sabatine; David A. Johnson; Frances Chan; Neena S. Abraham; Eamonn Martin Quigley

doi:10.1016/j.jacc.2009.09.012

Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures

Richard C. Becker, James Scheiman, Harold L. Dauerman, Frederick Spencer, Sunil Rao, Marc Sabatine, David A. Johnson, Frances Chan, Neena S. Abraham, Eamonn Martin Quigley

Research output: Contribution to journal › Review article

32 Scopus citations

Abstract

The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

Original language	English (US)
Pages (from-to)	2261-2276
Number of pages	16
Journal	Journal of the American College of Cardiology
Volume	54
Issue number	24
DOIs	https://doi.org/10.1016/j.jacc.2009.09.012
State	Published - Dec 8 2009

Keywords

coronary heart disease
periprocedural risk assessment
platelet antagonists

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2009.09.012

Fingerprint Dive into the research topics of 'Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures'. Together they form a unique fingerprint.

Cite this

Becker, R. C., Scheiman, J., Dauerman, H. L., Spencer, F., Rao, S., Sabatine, M., Johnson, D. A., Chan, F., Abraham, N. S., & Quigley, E. M. (2009). Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures. Journal of the American College of Cardiology, 54(24), 2261-2276. https://doi.org/10.1016/j.jacc.2009.09.012

Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures. / Becker, Richard C.; Scheiman, James; Dauerman, Harold L.; Spencer, Frederick; Rao, Sunil; Sabatine, Marc; Johnson, David A.; Chan, Frances; Abraham, Neena S.; Quigley, Eamonn Martin.

In: Journal of the American College of Cardiology, Vol. 54, No. 24, 08.12.2009, p. 2261-2276.

Research output: Contribution to journal › Review article

Becker, RC, Scheiman, J, Dauerman, HL, Spencer, F, Rao, S, Sabatine, M, Johnson, DA, Chan, F, Abraham, NS & Quigley, EM 2009, 'Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures', Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2261-2276. https://doi.org/10.1016/j.jacc.2009.09.012

Becker, Richard C. ; Scheiman, James ; Dauerman, Harold L. ; Spencer, Frederick ; Rao, Sunil ; Sabatine, Marc ; Johnson, David A. ; Chan, Frances ; Abraham, Neena S. ; Quigley, Eamonn Martin. / Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures. In: Journal of the American College of Cardiology. 2009 ; Vol. 54, No. 24. pp. 2261-2276.

@article{a9d4d27441744c5facca984616052319,

title = "Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures",

abstract = "The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.",

keywords = "coronary heart disease, periprocedural risk assessment, platelet antagonists",

author = "Becker, {Richard C.} and James Scheiman and Dauerman, {Harold L.} and Frederick Spencer and Sunil Rao and Marc Sabatine and Johnson, {David A.} and Frances Chan and Abraham, {Neena S.} and Quigley, {Eamonn Martin}",

year = "2009",

month = dec,

day = "8",

doi = "10.1016/j.jacc.2009.09.012",

language = "English (US)",

volume = "54",

pages = "2261--2276",

journal = "Journal of the American College of Cardiology.",

issn = "0735-1097",

publisher = "Elsevier",

number = "24",

}

TY - JOUR

T1 - Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures

AU - Becker, Richard C.

AU - Scheiman, James

AU - Dauerman, Harold L.

AU - Spencer, Frederick

AU - Rao, Sunil

AU - Sabatine, Marc

AU - Johnson, David A.

AU - Chan, Frances

AU - Abraham, Neena S.

AU - Quigley, Eamonn Martin

PY - 2009/12/8

Y1 - 2009/12/8

N2 - The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

AB - The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

KW - coronary heart disease

KW - periprocedural risk assessment

KW - platelet antagonists

UR - http://www.scopus.com/inward/record.url?scp=70649088108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70649088108&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2009.09.012

DO - 10.1016/j.jacc.2009.09.012

M3 - Review article

C2 - 19942393

AN - SCOPUS:70649088108

VL - 54

SP - 2261

EP - 2276

JO - Journal of the American College of Cardiology.

JF - Journal of the American College of Cardiology.

SN - 0735-1097

IS - 24

ER -